Relative bioavailability of deferasirox tablets administered without dispersion and dispersed in various drinks.

Author: BalezS, BrunE, DumortierT, DutreixC, MorissonS, PommierF, SéchaudR

Paper Details 
Original Abstract of the Article :
Deferasirox (ExjadeA, ICL670) is a new, once-daily oral iron chelator, recently approved as first-line therapy in the treatment of iron overload resulting from blood transfusions. In registration studies, deferasirox tablets were dispersed in non-carbonated water prior to administration. In routine ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.5414/cpp46102

データ提供:米国国立医学図書館(NLM)

Deferasirox: A Camel's Journey Through the Desert of Iron Overload

The field of hematology is a vast desert, where we navigate the intricate world of blood disorders. Iron overload, a condition where the body accumulates excess iron, can lead to serious health problems. Deferasirox is a medication used to treat iron overload, and this study investigates its bioavailability when administered in different ways. Researchers compared the bioavailability of deferasirox tablets when taken without dispersion and dispersed in various drinks. Their findings showed that deferasirox bioavailability was similar regardless of the method of administration.

Navigating the Sands of Iron Overload Treatment

This research provides valuable insights into the bioavailability of deferasirox, a medication used to treat iron overload. The study's findings offer reassurance that the method of administration does not significantly impact the drug's effectiveness. Understanding these factors is crucial for ensuring optimal treatment outcomes for patients with iron overload.

A Camel's Perspective on Blood Health

This research reminds us of the importance of understanding the intricacies of drug administration and bioavailability. The study's findings highlight the need for careful consideration of these factors to ensure effective treatment outcomes. By staying informed about these nuances, we can navigate the desert of blood disorders with greater knowledge and confidence.

Dr. Camel's Conclusion

This research provides valuable insights into the bioavailability of deferasirox, a medication used to treat iron overload. The study's findings suggest that the method of administration does not significantly impact the drug's effectiveness. As Dr. Camel, I am always seeking knowledge that can improve treatment outcomes for those facing health challenges, and this research serves as a reminder of the importance of understanding drug administration and bioavailability.

Date :
  1. Date Completed 2008-05-22
  2. Date Revised 2019-06-08
Further Info :

Pubmed ID

18218291

DOI: Digital Object Identifier

10.5414/cpp46102

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.